Bliss GVS Pharma Limited
BLISSGVS.BO · Bombay Stock Exchange · INR
651,10INR
+31,00 (+5,00 %)Stand 9. Nov., 9:57
Kennzahlen
- Eröffnung
- 623,70
- Vortag
- 620,10
- Tagesspanne
- 605,25 – 651,10
- 52 Wochen
- 118,35 – 744,75
- Volumen
- 4698
- Ø Volumen
- 20.064
- Börsenwert
- 69,69 Mrd. INR
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 1,1
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
Bliss GVS Pharma Limited, founded in 1984 and based in Mumbai, India, operates as a pharmaceutical enterprise focused on the development, production, and commercialization of a vast array of medicinal formulations and general healthcare items. Its comprehensive pharmaceutical offerings span numerous dosage forms, such as capsules, tablets, injections, oral suspensions, topical creams/gels/ointments, effervescent tablets, eye/ear drops, transdermal patches, and parenterals. In addition to prescription pharmaceuticals, the company manufactures a wide selection of over-the-counter (OTC) and personal care products, including balms, lotions, shampoos, soaps, nasal inhalers, and various sprays and solutions. Addressing a broad spectrum of medical conditions, Bliss GVS's therapeutic catalogue features anti-infectives (e.g., antibacterial, anti-malarial, anti-fungal), anti-inflammatory agents, analgesics, gastrointestinal treatments (such as anti-ulcer and anti-diarrheal medications), anti-diabetics, respiratory support products (like antitussives and nasal decongestants), and an extensive range of nutritional, dermatological, and general wellness supplements, including vitamins, body supplements, and specialized hygiene solutions. The company's products are also distributed internationally through its export operations.
- CEO
- Shibroor Narsimha Kamath
- Mitarbeitende
- 1.033
- Hauptsitz
- Mumbai, MA, IN
- Sektor
- Healthcare
- Branche
- Drug Manufacturers - Specialty & Generic
- Börsengang
- 11. Jan. 2002
- Website
- blissgvs.com
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.